Deliver Your News to the World

Are NDM-Producing CRE Infections Spreading Outside of Healthcare Settings?

EMSL Analytical, Inc. offers environmental testing services to identify microbial pathogens to help prevent infections and outbreaks.


Cinnaminson, NJ – WEBWIRE

In December, the Centers for Disease Control and Prevention (CDC) published information about six patients in Colorado who are believed to have acquired community-associated, New Delhi metallo-β-lactamase (NDM) producing Carbapenem-resistant Enterobacteriaceae (CRE). NDM-producing CRE is an emerging global superbug threat that in the past has primarily been associated with healthcare exposures, such as hospitalizations, outside of the United States.

CRE are a family of germs that are difficult to treat because they have high levels of resistance to antibiotics. Carbapenem describes a class of antibiotics that is frequently used to treat severe infections and is often considered the antibiotics of last resort.   

“The CDC reports that healthy people usually do not get CRE infections and they usually happen to patients in hospitals, nursing homes and other healthcare settings,” said Jason Dobranic, Ph.D., Vice President of Microbiology and Life Sciences at EMSL Analytical, Inc. “The potential for six people in one state to have come down with NDM-producing CRE in the community is a significant development as these types of infections are extremely difficult to treat.”

CRE infections can contribute to death in up to 50% of patients according to some reports. To help prevent the spread of CRE and other superbugs, EMSL Analytical, Inc. provides environmental testing services to identify their presence. These services are instrumental for identifying contaminated surfaces and instruments in healthcare and community environments. Testing is also important for confirming that cleaning and disinfection procedures are effective, especially in places where people could be at increased risk or where an outbreak has already occurred.

EMSL has sponsored an educational video about Carbapenem-resistant Enterobacteriaceae that can be seen at: https://www.youtube.com/watch?v=x3HE6FfDYLQ.

To learn more about environmental testing services for microbial pathogens, please visit www.EMSL.com, email  info@EMSL.com  or call (800) 220-3675.

About EMSL Analytical, Inc.

EMSL Analytical is one of the leading testing laboratories with over 40 locations throughout the United States and Canada. EMSL is a nationally recognized and locally focused provider specializing in fast laboratory results for mold, bacteria, Legionella, USP 797, pathogens, asbestos, lead, soot, char & ash from fires, VOC’s, odors, radon, formaldehyde, indoor air quality, microbiology, environmental, industrial hygiene, radiological, food, beverage & consumer products and material testing services for the identification of unknown substances. EMSL services both professionals and the general public. EMSL maintains an extensive list of accreditations from leading organizations as well as state and federal regulating bodies including, but not limited to A2LA, AIHA LAP, LLC. (AIHA EMLAP, AIHA IHLAP, AIHA ELLAP), NVLAP, CDC ELITE, CPSC, CA ELAP, NY ELAP, TX DOH, NJDEP and multiple other state accrediting agencies. Please visit our website at www.EMSL.com for a complete listing of accreditations. In addition, EMSL carries a wide range of Sampling Equipment and Investigative Products for environmental professionals.
 


( Press Release Image: http://photos.webwire.com/prmedia/9645/207897/207897-1.jpg )


WebWireID207897




 
 Carbapenem-resistant
 superbug
 antibiotic
 NDM-producing
 healthcare


This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.